Award Recipients

Excellence In Research Awards

The 2018 ASGCT Excellence in Research Awards were presented on Tuesday, April 30 during the George Stamatoyannopoulos Memorial Lecture to the following researchers:

Filippo Birocchi

San Raffaele Telethon
Institute for Gene Therapy

Allison Bradbury, Ph.D.

University of Pennsylvania

Alessio Cantore, Ph.D.

San Raffaele Telethon
Institute for Gene Therapy

Daniela Cesana

San Raffaele Telethon
Institute for Gene Therapy

Amanda Dudek, Ph.D.

Grousbeck Gene Therapy Center,
Mass Eye and Ear,
Harvard Medical School

Samuel Huang

Oregon Health and Science University

Hak Kyun Kim, DPhil

Stanford University

Chang Li, Ph.D.

University of  Washington

Richard Morgan

University of California, Los Angeles

Christopher Nelson, Ph.D.

Duke University

Giulia Pavani, Ph.D.

Genethon

Afrooz Rashnonejad, Ph.D.

Nationwide Children's Hospital

Dimah Saade, Ph.D.

NINDS, NIH

Giulia Schiroli, Ph.D.

San Raffaele Telethon
Institute for Gene Therapy

Meredith Sosulski, Ph.D.

Weill Cornell Medical College

Anne Vonada

Oregon Health and Science University

The 2019 Excellence in Research Awards are made possible by the generous sponsorship of:


Travel Awards

The 2018 ASGCT Meritorious and Underrepresented Minority Travel Awards were presented during the respective presentations of the awardees at the 21st Annual Meeting:

Kaothara Adeyanju

Aisha AlJanahi

Filippo Birocchi

Daniel Bittel

Matthias Bozza

Allison Bradbury

Mariana Bravo-Hernandez

Mitchell Brun

John Butterfield

Suvd Byambaa

Alessio Cantore

Sean Carrig

Antonio Carusillo

Jessica Centa

Ana Cepeda Diaz

Daniela Cesana

Ying Kai Chan

Shyambabu Chaurasiya

Valery Chavez

Chun-Yu Chen

Beatrice Cianciotti

Pasqualina Colella

Julie Crudele

Alessia De Caneva

Joanne Marie Del Rosario

Nathan Delvaux

Peter Deng

Amanda Dudek

Corey Duke

Nicholas Economos

Chelsea Edelblute

Eric Ehrke-Schulz

Lauren Fleischer

Christos Georgiadis

Gwladys Gernoux

Trevor Gonzalez

Veronica Gough

Beatrice Greco

Amanda Gross

Julian Grünewald

Simone Hager

Mohamad Hamieh

Jiaying Han

L Havlik

Mareike Hoffmann

Samuel Huang

Raed Ibraheim

Julia Joo

Maja Kalbarczyk

Xi Kang

Hye Ri Kang

Megan Keiser

Hak Kyun Kim

Swapna Kollu

Biao Kuang

Elisa Landoni

Rachael Levings

Xinghuo Li

Chang Li

Telmo Llanga

Kevin Luk

Mirko Luoni

Victoria Madigan

Laura Marquez Loza

Rika Maruyama

R Mellen

Mario Mietzsch

Feiyan Mo

Leon Morales

Richard Morgan

Mustafa Munye

Kelsey Murphy

Christopher Nelson

Matthew Nitzahn

Ashlesha Odak

Nandakumar Packiriswamy

Helena Palau

Eleni Panagioti

Giulia Pavani

Christopher Petersen

Karl Petri

Anastasia Petrova

Benjamin Philipson

Adrian Pickar-Oliver

Alexandra Piotrowski-Daspit

Brooke Prinzing

Nikoleta Psatha

Elias Quijano

Shuquan Rao

Afrooz Rashnonejad

Steven Rheiner

Alicia Roig-Merino

Blake Rust

Dimah Saade

Andrew Satterlee

Giulia Schiroli

Sandhya Sharma

Jamie Shirley

Surya Shrivastava

Anze Smole

Laura Spector

Sabrina Sun

Takahiro Tadokoro

Toloo Taghian

Kazuhiro Takahama

Amita Tiyaboonchai

Patrizia Tornabene

Gabriela Toro Cabrera

Brian Truong

Mildred Unti

Valentina Vavassori

Monica Volpin

Anne Vonada

Hongjie Wang

Huawei Wang

Jiao Wang

Volker Wiebking

David Wilson

Meiyu Xu

Hua Yang

Hideki Yoshida

Carolyn Yrigollen

Mihaela Zabulica

Markella Zannikou

Xintao Zhang

Detu Zhu

       

The 2019 ASGCT Travel Awards are made possible by the generous support of the following sponsors:


2019 Outstanding Poster Award Winners

Basel T. Assaf—Pfizer Inc.
Preclinical Evaluation of an AAV-Based Gene Therapy Approach for the Treatment of Friedreich Ataxia Cardiomyopathy

Enrico R. Barrozo—University of Florida, Gainesville
AAV-Mediated Ribozyme Gene Therapy for Ocular Herpes

Camilo Breton—University of Pennsylvania
Meganuclease Suicide System, a Self-Inactivation Method to Reduce Nuclease Expression and Off-Target Activity

Jessika Ceiler—National Center for Tumor Diseases and German Cancer Research Center
Wild-Type and Recombinant AAV: Novel Insights into Mitochondrial Integration and Trafficking

ZeNan L. Chang—University of California, Los Angeles
Rewiring T-Cell Signaling Responses to Extracellular Soluble Cues with Chimeric Antigen Receptors

Eun-Young Choi—NICHD, NIH
AAV6-Mediated Choroid Plexus-Targeted Gene Therapy for Alpha-Mannosidosis

Rebecca Cooper—Biogen
Optimizing Residual DNA Detection for Gene Therapy Programs

Sarah Isabel Davies—National Heart, Lung, and Blood Institute
Merkel Cell Polyomavirus Oncoprotein-Specific T Cells Generated from Healthy Donors for Potential Adoptive Immunotherapy

Benjamin Deverman—Broad Institute of MIT and Harvard
Elucidating the Mechanism of Blood-Brain Barrier Transcytosis by the Engineered AAV-PHP.B Capsids: A Critical Step towards Developing AAV Capsids for Human Gene Therapy

Giacomo Frati—INSERM
Fetal Hemoglobin De-Repression Following CRISPR/Cas9 Mediated Targeting of the γ-Globin Promoters as a Therapeutic Strategy foR β-Hemoglobinopathies

Christopher D. Greer—University of Pennsylvania
Implications of Deep Evolutionary History of Locomotion for Muscular Dystrophy Transgene Design

Akihito Inagaki—University of California, San Francisco
Retroviral Replicating Vector-Mediated Prodrug Activator Gene Therapy with Engineered Human Mesenchymal Stem Cells in an Experimental Glioma Model

Lori B. Karpes—Voyager Therapeutics
Stability of rAAV Vectors: Response to Various Biochemical and Biophysical Stresses

Shiron J. Lee—University of Toronto
Developing Gene Therapy for Treating Intractable Epilepsy in Dravet Syndrome

Laura I. Marquez Loza—University of Iowa
Codon Optimization Enhances Functional Cystic Fibrosis Transmembrane Conductance Regulator Expression

Wren Michaels—Chicago Medical School, Rosalind Franklin University of Medicine and Science
Splice-Switching Antisense Oligonucleotides for the Treatment of Cystic Fibrosis

Leon Morales—University of Pennsylvania
Utrophin Vector Protected by Central Tolerance as Potential Cure for Muscular Dystrophy

Sara Regio—CHUV (Lausanne University Hospital)
A Single Vector Approach in the Self-Inactivating KamiCas9 System with a Viral-Mediated Retrograde Transport

Rebecca E. Ryan—Emory University
Optimizing Gamma Delta T Cells Expansion for Cell-Based Immunotherapies

Abdul Mohin Sajib—Auburn University
Precise Genetic Modification of Canine Adenovirus Type 2 (CAV2) Genome by CRISPR/CAS9

Nina Semenova—Old Dominion University
Cytoplasmic Nucleic Acids Sensing in Mouse Myoblasts after Plasmid DNA Transfection: Potential Involvement of Multiple Proteins

Tracey L. Smith—Rutgers New Jersey Medical School
Targeted AAVP-Based Therapy in a Mouse Model of Human Glioblastoma: A Comparison of Cytotoxic Versus Suicide Gene Delivery Strategies

Nolan D. Sutherland—bluebird bio
The Ambr 15 System as a Screening Tool for Lentiviral Vector Process Development

Manuela Urban—DNA Vectors, DKFZ
Utilising Non-Viral Episomal S/MAR DNA Vectors for the Persistent Genetic Modification of hiPSCs

Guan Wang—University of Southern California, Los Angeles
Immunodominant and Cryptic Tumor Neoantigen Specific Immune Responses Activated by an Armed Oncolytic Virus Expressing a PD-L1 Inhibitor

Elizabeth Weisman—Obsidian Therapeutics
Regulation of CD40L Transgene Expression in Human CAR-T Cells Using FDA Approved Ligands

Lane H. Wilson—University of Connecticut School of Medicine
Effects of PhK Deficiency in a Mouse Model of Glycogen Storage Disease Type IX